Reykjavik, Iceland

Patrick Sulem

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Reykjavík, IS (2013)
  • Reyjavik, IS (2014)
  • Reykjavik, IS (2013 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: **Patrick Sulem: Pioneer in Genetic Innovations from Reykjavik**

Introduction

Patrick Sulem, a prominent inventor based in Reykjavik, Iceland, has made significant contributions to the field of genetics. With a portfolio of seven patents, his work focuses primarily on genetic variants that assess the risk of common cancers, including breast and prostate cancer. His innovative approach has advanced methods for disease management and predictive analytics in oncology.

Latest Patents

Patrick Sulem's latest patents reflect his commitment to improving cancer risk assessment. One notable invention, titled "Genetic variants for breast cancer risk assessment," addresses susceptibility variants related to breast cancer. This invention not only outlines methods for diagnosing increased susceptibility but also includes predictive measures for therapy responses and prognosis using the identified genetic variants. Additionally, he has developed kits that facilitate these diagnostic methods.

Another groundbreaking patent is titled "Genetic variants contributing to risk of prostate cancer." This innovation identifies specific genetic variants linked to susceptibility for prostate cancer. The invention encompasses methods for assessing both increased and decreased susceptibility to prostate cancer, further enhancing clinical understanding and management of this disease, alongside kits designed for determining susceptibility.

Career Highlights

Patrick Sulem is affiliated with Decode Genetics Ehf, where his research aligns with the company's mission of utilizing genetic data to foster advancements in healthcare. His work at Decode Genetics reflects a passion for leveraging genetic insights to improve patient outcomes in cancer treatment and management.

Collaborations

Throughout his career, Sulem has collaborated with notable coworkers, including Thorgeir E. Thorgeirsson and Frank Geller. These partnerships have facilitated the exchange of knowledge and expertise, further enriching Sulem's contributions to genetic research and innovation.

Conclusion

Patrick Sulem stands out as an influential figure in the realm of genetic innovations, particularly concerning cancer risk assessment. His patents and work at Decode Genetics showcase a dedication to enhancing medical practices through scientific discoveries. As research in genetics continues to evolve, Sulem's contributions will undoubtedly play a pivotal role in shaping future advancements in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…